HOME >> BIOLOGY >> NEWS
Uncertainty in clinical tests raises health care costs

Small measurement uncertainties in clinical laboratory tests can add large amounts to health care costs, according to a newly released study commissioned by the National Institute of Standards and Technology (NIST).

The study,* conducted by RTI International (Research Triangle Park, N.C.) and the Mayo Clinic (Rochester, Minn.), estimates that calibration errors in measurements of calcium levels in blood may add between $60 million and $199 million to U.S. health care costs annually. High calcium levels can be a symptom of diseases such as cancer and thyroid disorders.

Accurate measurements are critical because calcium levels in healthy people fall within a narrow range, between 8.9 to 10.1 milligrams (mg) per deciliter (dL). Through interviews with laboratory managers and equipment manufacturers, the researchers estimated that results for up to 15 percent of calcium laboratory tests contain calibration errors of between 0.1 and 0.5 mg per dL. This means that some results that fall in the center of the "normal" range, say 9.7 mg/dL, may in fact be for patient samples with elevated calcium, defined as 10.2 mg/dL and above. At the same time, patients with measured values above the threshold, but who actually have normal calcium levels, may receive unnecessary follow-up procedures such as hormone measurements and chest X-rays.

The study analyzed data for more than 89,000 patients receiving serum calcium tests at the Mayo Clinic from 1998 to 1999. It found that calibration errors added between $8 and $89 per patient to the health care costs of approximately 3.55 million patients.

Major sources of calibration error include differences in analysis methods used by different laboratory instruments, lot-to-lot variations in calibration materials, and lack of "traceability" between secondary reference materials and primary standards such as Standard Reference Materials produced by NIST.


'"/>

Contact: Laura Ost
laura.ost@nist.gov
301-975-4034
National Institute of Standards and Technology (NIST)
7-May-2004


Page: 1

Related biology news :

1. Preclinical safety study shows adipose-derived stem cells improve heart function after heart attack
2. First clinical study of new pediatric croup vaccine shows safety, tolerability in adults
3. Innovative ceramic-on-metal hip replacements to undergo clinical trials
4. Early clinical treatment can halt progression of Alzheimers disease, UCI researchers find
5. Warren Pharmaceuticals publishes results of preclinical evaluation
6. Creation of the UK Clinical Research Collaboration will boost clinical trials in UK
7. Scientists characterize new breast tumor subtypes with poor clinical outcomes
8. Vanderbilts John Oates wins clinical research award
9. Germany starts clinical development of a new tuberculosis vaccine
10. Heart and lung transplantation clinical trial results to be announced at ISHLT meeting
11. Genetic profile, not clinical appearance, to determine tumor treatment

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/6/2020)... , ... February 06, 2020 ... ... research organization (CRO) specializing in complex interventional medical device and pharmaceutical trials, ... Regulatory Strategy. In this newly established role, Dorothy oversees the development and ...
(Date:2/5/2020)... ... February 05, 2020 , ... LabKey has released Sample Manager, ... to sample processing within laboratories. , Built with input from a Product ... fields, LabKey Sample Manager has been designed with an intuitive user interface providing ...
(Date:1/29/2020)... ... January 29, 2020 , ... Jason Burke has joined CREO, ... providing consulting services for strategy, research and development and data governance to healthcare ... Managing Partner of CREO, an innovative management consulting and advisory firm based in ...
Breaking Biology News(10 mins):
(Date:1/27/2020)... , ... January 27, 2020 , ... ... it has secured financing from strategic investors led by Halma plc , ... existing investors Sonion, TDF Ventures, GII LLC, and WSJ Joshua Fund. A representative ...
(Date:1/22/2020)... ... January 20, 2020 , ... Brilliant, maker of ... the largest independent electronics distributor in the US, to make it easy for ... with leading smart home products from a single fulfillment partner. Ranging from entry-level ...
(Date:1/10/2020)... ... January 09, 2020 , ... ... services, today announced the acquisition of Cunesoft, a move that expands the company’s ... objectives of life sciences companies. , Based in Munich, Germany, Cunesoft provides intelligent ...
(Date:1/7/2020)... ... January 07, 2020 , ... Vuja De Sciences (“Vuja De”), ... recurrence, today announced the appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. ... Vuja De said, “We are delighted to welcome Chand and Lee as new directors. ...
Breaking Biology Technology:
Cached News: